Snowden Capital Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Snowden Capital Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Snowden Capital Advisors from 13F filings

Historical chart of Snowden Capital Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Snowden Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $368k 3.5k 103.88
2021-12-31 $7.0k 100 70.00

More positions owned by Snowden Capital Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Spdr Series Trust State Street Spd (SPYM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Snowden Capital Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
British Columbia Investment Management Corporation
Employees Retirement System of Texas
Royal Bank of Canada
J.Safra Asset Management
Tower Research Capital
Avalon Trust
Citigroup
Gts Securities
Morgan Stanley
Adamsbrown Wealth Consultants
Bank of America Corporation

View all funds holding Vaneck Vectors Pharmaceutical etf